Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease

Open access
Cangiano, Biagio, Swee, Du Soon, Quinton, Richard, Bonomi, Marco · 2021 · Human Genetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00439-020-02147-1

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 243

  1. Abreu AP, Trarbach EB, de Castro M et al (2008) Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab 93:4113–4118. https://doi.org/10.1210/jc.2008-0958 · DOI · Paper page
  2. Abreu AP, Noel SD, Xu S et al (2012) Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function. Mol Endocrinol 26:1417–1427. https://doi.org/10.1210/me.2012-1102 · DOI
  3. Alatzoglou KS, Kelberman D, Cowell CT et al (2011) Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2010-1239 · doi:10.1210/jc.2010-1239
  4. Avilion AA, Nicolis SK, Pevny LH et al (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17:126–140. https://doi.org/10.1101/gad.224503 · DOI · Paper page
  5. Ayari B, Soussi-Yanicostas N (2007) FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs. Dev Genes Evol 217:169–175. https://doi.org/10.1007/s00427-006-0125-0 · DOI · Paper page
  6. Bach I, Rhodes SJ, Pearse RV et al (1995) P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.92.7.2720 · DOI · Paper page
  7. Balasubramanian R, Chew S, MacKinnon SE et al (2015) Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome. J Clin Endocrinol Metab 100:E473–E477. https://doi.org/10.1210/jc.2014-4107 · DOI
  8. Basaran Y, Bolu E, Unal HU et al (2013) Multiplex ligation dependent probe amplification analysis of KAL1, GNRH1, GNRHR, PROK2 and PROKR2 in male patients with idiopathic hypogonadotropic hypogonadism. Endokrynol Pol 64:285–292. https://doi.org/10.5603/EP.2013.0007 · DOI
  9. Basciani S, Watanabe M, Mariani S et al (2012) Hypogonadism in a patient with two novel mutations of the luteinizing hormone β-subunit gene expressed in a compound heterozygous form. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2012-1986 · DOI
  10. Bencharit S, Bin CC, Siddiqui A et al (2007) Structural insights into fibronectin type III domain-mediated signaling. J Mol Biol 367:303–309. https://doi.org/10.1016/j.jmb.2006.10.017 · doi:10.1016/j.jmb.2006.10.017
  11. Beranova M, Oliveira LM, Bédécarrats GY et al (2001) Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 86:1580–1588. https://doi.org/10.1210/jcem.86.4.7395 · DOI · Paper page
  12. Bernard G, Chouery E, Putorti ML et al (2011) Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 89:415–423. https://doi.org/10.1016/j.ajhg.2011.07.014 · DOI · Paper page
  13. Bhagavath B, Podolsky RH, Ozata M et al (2006) Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil Steril 85:706–713. https://doi.org/10.1016/j.fertnstert.2005.08.044 · DOI
  14. Bhangoo APS, Hunter CS, Savage JJ et al (2006) A novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab 91(3):747–753. https://doi.org/10.1210/jc.2005-2360 · DOI
  15. Bonfig W, Krude H, Schmidt H (2011) A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck—a case report and review of the literature. Eur J Pediatr. https://doi.org/10.1007/s00431-011-1393-x · DOI
  16. Bonomi M, Libri DV, Guizzardi F et al (2012) New understandings of the genetic basis of isolated idiopathic central hypogonadism. Asian J Androl 14:49–56. https://doi.org/10.1038/aja.2011.68 · DOI
  17. Bonomi M, Vezzoli V, Krausz C et al (2018) Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH). Eur J Endocrinol 178:23–32. https://doi.org/10.1530/EJE-17-0065 · DOI
  18. Böttcher RT, Pollet N, Delius H, Niehrs C (2004) The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling. Nat Cell Biol. https://doi.org/10.1038/ncb1082 · DOI · Paper page
  19. Bouilly J, Messina A, Papadakis G et al (2018) DCC/NTN1 complex mutations in patients with congenital hypogonadotropic hypogonadism impair GnRH neuron development. Hum Mol Genet 27:359–372. https://doi.org/10.1093/hmg/ddx408 · DOI
  20. Bouligand J, Ghervan C, Tello JA et al (2009) Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N Engl J Med 360:2742–2748. https://doi.org/10.1056/NEJMoa0900136 · DOI · Paper page
  21. Breuskin I, Bodson M, Thelen N et al (2009) Sox10 promotes the survival of cochlear progenitors during the establishment of the organ of Corti. Dev Biol. https://doi.org/10.1016/j.ydbio.2009.09.007 · DOI
  22. Brioude F, Bouligand J, Trabado S et al (2010) Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. Eur J Endocrinol 162:835–851. https://doi.org/10.1530/EJE-10-0083 · DOI
  23. Bülow HE, Berry KL, Topper LH et al (2002) Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc Natl Acad Sci USA 99:6346–6351. https://doi.org/10.1073/pnas.092128099 · DOI · Paper page
  24. Cangiano B, Duminuco P, Vezzoli V et al (2019) Evidence for a common genetic origin of classic and milder adult-onset forms of isolated hypogonadotropic hypogonadism. J Clin Med. https://doi.org/10.3390/jcm8010126 · DOI
  25. Cariboni A, Pimpinelli F, Colamarino S et al (2004) The product of X-linked Kallmann’s syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet 13:2781–2791. https://doi.org/10.1093/hmg/ddh309 · DOI
  26. Cariboni A, Davidson K, Rakic S et al (2011) Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism. Hum Mol Genet 20:336–344. https://doi.org/10.1093/hmg/ddq468 · DOI
  27. Cariboni A, André V, Chauvet S et al (2015) Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome. J Clin Invest 125:2413–2428. https://doi.org/10.1172/JCI78448 · DOI
  28. Casoni F, Malone SA, Belle M et al (2016) Development of the neurons controlling fertility in humans: new insights from 3D imaging and transparent fetal brains. Development 143:3969–3981. https://doi.org/10.1242/dev.139444 · DOI · Paper page
  29. Cassatella D, Howard SR, Acierno JS et al (2018) Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures. Eur J Endocrinol 178:377–388. https://doi.org/10.1530/EJE-17-0568 · DOI
  30. Cattanach BM, Iddon CA, Charlton HM et al (1977) Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269:338–340. https://doi.org/10.1038/269338a0 · DOI · Paper page
  31. Cavalcante JC, Bittencourt JC, Elias CF (2014) Distribution of the neuronal inputs to the ventral premammillary nucleus of male and female rats. Brain Res 1582:77–90. https://doi.org/10.1016/j.brainres.2014.07.034 · DOI
  32. Cerrato F, Shagoury J, Kralickova M et al (2006) Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur J Endocrinol 155(Suppl):S3–S10. https://doi.org/10.1530/eje.1.02235 · DOI
  33. Ceylan AC, Gursoy H, Yildirim N et al (2017) Clinical heterogeneity associated with TUBB3 gene mutation in a Turkish family with congenital fibrosis of the extraocular muscles. Ophthalmic Genet 38:288–290. https://doi.org/10.1080/13816810.2016.1193881 · doi:10.1080/13816810.2016.1193881
  34. Chan Y-M, de Guillebon A, Lang-Muritano M et al (2009) GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 106:11703–11708. https://doi.org/10.1073/pnas.0903449106 · DOI · Paper page
  35. Charles MA, Saunders TL, Wood WM et al (2006) Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol. https://doi.org/10.1210/me.2005-0378 · DOI · Paper page
  36. Chew S, Balasubramanian R, Chan W-M et al (2013) A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain 136:522–535. https://doi.org/10.1093/brain/aws345 · DOI
  37. Chung WCJ, Tsai P-S (2010) Role of fibroblast growth factor signaling in gonadotropin-releasing hormone neuronal system development. Kallmann syndrome and hypogonadotropic hypogonadism. KARGER, Basel, pp 37–50 · DOI
  38. Chung WCJ, Matthews TA, Tata BK, Tsai PS (2010) Compound deficiencies in multiple fibroblast growth factor signalling components differentially impact the murine gonadotrophin-releasing hormone system. J Neuroendocrinol. https://doi.org/10.1111/j.1365-2826.2010.02024.x · DOI
  39. Cioppi F, Riera-Escamilla A, Manilall A et al (2019) Genetics of ncHH: from a peculiar inheritance of a novel GNRHR mutation to a comprehensive review of the literature. Andrology 7:88–101. https://doi.org/10.1111/andr.12563 · DOI
  40. Costa EMF, Bedecarrats GY, Mendonca BB et al (2001) Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction1. J Clin Endocrinol Metab 86:2680–2686. https://doi.org/10.1210/jcem.86.6.7551 · DOI
  41. Costa-Barbosa FA, Balasubramanian R, Keefe KW et al (2013) Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab 98:E943–E953. https://doi.org/10.1210/jc.2012-4116 · DOI · Paper page
  42. Cox KH, Oliveira LMB, Plummer L et al (2018) Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency. Hum Mol Genet 27:338–350. https://doi.org/10.1093/hmg/ddx404 · DOI
  43. Cravo RM, Frazao R, Perello M et al (2013) Leptin signaling in Kiss1 neurons arises after pubertal development. PLoS ONE 8:e58698. https://doi.org/10.1371/journal.pone.0058698 · DOI · Paper page
  44. Dai W, Wu J, Zhao Y et al (2019) Functional analysis of SOX10 mutations identified in Chinese patients with Kallmann syndrome. Gene 702:99–106. https://doi.org/10.1016/j.gene.2019.03.039 · DOI
  45. Daoud H, Tétreault M, Gibson W et al (2013) Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. J Med Genet 50:194–197. https://doi.org/10.1136/jmedgenet-2012-101357 · DOI · Paper page
  46. Dasen JS, Rosenfeld MG (2001) Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci 24:327–355. https://doi.org/10.1146/annurev.neuro.24.1.327 · DOI · Paper page
  47. Dattani MT, Robinson IC (2000) The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 57(5):337–346. https://doi.org/10.1034/j.1399-0004.2000.570503.x · DOI
  48. Dattani MT, Martinez-Barbera JP, Thomas PQ et al (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet. https://doi.org/10.1038/477 · DOI · Paper page
  49. Diaczok D, Divall S, Matsuo I et al (2011) Deletion of Otx2 in GnRH neurons results in a mouse model of hypogonadotropic hypogonadism. Mol Endocrinol. https://doi.org/10.1210/me.2010-0271 · DOI
  50. Dodé C, Hardelin J-P (2009) Kallmann syndrome. Eur J Hum Genet 17:139–146. https://doi.org/10.1038/ejhg.2008.206 · DOI · Paper page
  51. Dodé C, Levilliers J, Dupont JM et al (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. https://doi.org/10.1038/ng1122 · DOI · Paper page
  52. Duan J, Chen R-R, Li L et al (2014) Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients. Asian J Androl. https://doi.org/10.4103/1008-682X.145072 · DOI
  53. Duke VM, Winyard PJD, Thorogood P et al (1995) KAL, a gene mutated in Kallmann’s syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 110:73–79. https://doi.org/10.1016/0303-7207(95)03518-C · DOI
  54. Dwyer AA, Smith N, Quinton R (2019b) Psychological aspects of congenital hypogonadotropic hypogonadism. Front Endocrinol (Lausanne) 10:353. https://doi.org/10.3389/fendo.2019.00353 · DOI
  55. Dzemaili S, Tiemensma J, Quinton R et al (2017) Beyond hormone replacement: quality of life in women with congenital hypogonadotropic hypogonadism. Endocr Connect 6:404–412. https://doi.org/10.1530/EC-17-0095 · DOI
  56. Fang Q, Benedetti AFF, Ma Q et al (2016a) HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype. Clin Endocrinol (Oxf). https://doi.org/10.1111/cen.13067 · DOI
  57. Fang Q, George AS, Brinkmeier ML et al (2016) Genetics of combined pituitary hormone deficiency: roadmap into the genome era. Endocr Rev 37(6):636–675. https://doi.org/10.1210/er.2016-1101 · DOI · Paper page
  58. Fantes J, Ragge NK, Lynch S-A et al (2003) Mutations in SOX2 cause anophthalmia. Nat Genet 33:461–463. https://doi.org/10.1038/ng1120 · DOI · Paper page
  59. Farooqi IS (2002) Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med. https://doi.org/10.1055/s-2002-32505 · DOI
  60. Francou B, Bouligand J, Voican A et al (2011) Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations. PLoS ONE 6:e25614. https://doi.org/10.1371/journal.pone.0025614 · DOI
  61. Francou B, Paul C, Amazit L et al (2016) Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study. Hum Reprod 31:1363–1374. https://doi.org/10.1093/humrep/dew073 · DOI
  62. Fromantin M, Gineste J, Didier A, Rouvier J (1973) Impuberism and hypogonadism at induction into military service. Statistical study. Probl Actuels Endocrinol Nutr 16:179–199
  63. Galazzi E, Duminuco P, Moro M et al (2018) Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome. Endocr Connect 7:1432–1441. https://doi.org/10.1530/EC-18-0486 · DOI
  64. Gianetti E, Tusset C, Noel SD et al (2010) TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab 95:2857–2867. https://doi.org/10.1210/jc.2009-2320 · DOI · Paper page
  65. Gonçalves CI, Aragüés JM, Bastos M et al (2017) GNRHR biallelic and digenic mutations in patients with normosmic congenital hypogonadotropic hypogonadism. Endocr Connect 6:360–366. https://doi.org/10.1530/EC-17-0104 · DOI
  66. Gonçalves CI, Patriarca FM, Aragüés JM et al (2019) High frequency of CHD7 mutations in congenital hypogonadotropic hypogonadism. Sci Rep 9:1597. https://doi.org/10.1038/s41598-018-38178-y · DOI
  67. Gonzalez-Martinez D (2004) Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. J Neurosci 24:10384–10392. https://doi.org/10.1523/JNEUROSCI.3400-04.2004 · DOI
  68. Gorbenko Del Blanco D, Romero CJ, Diaczok D et al (2012) A novel OTX2 mutation in a patient with combined pituitary hormone deficiency, pituitary malformation, and an underdeveloped left optic nerve. Eur J Endocrinol. https://doi.org/10.1530/EJE-12-0333 · doi:10.1530/eje-12-0333
  69. Gottsch ML, Cunningham MJ, Smith JT et al (2004) A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145:4073–4077. https://doi.org/10.1210/en.2004-0431 · DOI · Paper page
  70. Habiby RL, Boepple P, Nachtigall L et al (1996) Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 98:1055–1062. https://doi.org/10.1172/JCI118866 · DOI · Paper page
  71. Haines DE, Mihailoff GA, Parent AD, Perkins E (2018) The hypothalamus. Fundam Neurosci Basic Clin Appl 442–456:e1. https://doi.org/10.1016/B978-0-323-39632-5.00030-X · doi:10.1016/b978-0-323-39632-5.00030-x
  72. Hanafusa H, Torii S, Yasunaga T, Nishida E (2002) Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 4:850–858. https://doi.org/10.1038/ncb867 · DOI · Paper page
  73. Hausott B, Vallant N, Schlick B et al (2012) Sprouty2 and -4 regulate axon outgrowth by hippocampal neurons. Hippocampus. https://doi.org/10.1002/hipo.20910 · DOI
  74. Henderson RH, Williamson KA, Kennedy JS et al (2009) A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Mol Vis 15:2442–2447
  75. Hirata T, Nakazawa M, Yoshihara S et al (2006) Zinc-finger gene Fez in the olfactory sensory neurons regulates development of the olfactory bulb non-cell-autonomously. Development 133:1433–1443. https://doi.org/10.1242/dev.02329 · DOI
  76. Hoffmann HM, Pandolfi EC, Larder R, Mellon PL (2019) Haploinsufficiency of homeodomain proteins Six3, Vax1, and Otx2 causes subfertility in mice via distinct mechanisms. Neuroendocrinology. https://doi.org/10.1159/000494086 · DOI
  77. Howard SR, Guasti L, Ruiz-Babot G et al (2016) IGSF 10 mutations dysregulate gonadotropin-releasing hormone neuronal migration resulting in delayed puberty. EMBO Mol Med 8:626–642. https://doi.org/10.15252/emmm.201606250 · DOI
  78. Howard SR, Oleari R, Poliandri A et al (2018) HS6ST1 insufficiency causes self-limited delayed puberty in contrast with other GnRH deficiency genes. J Clin Endocrinol Metab 103:3420–3429. https://doi.org/10.1210/jc.2018-00646 · DOI
  79. Huang H, Yang T, Shao Q et al (2018) Human TUBB3 mutations disrupt netrin attractive signaling. Neuroscience 374:155–171. https://doi.org/10.1016/j.neuroscience.2018.01.046 · DOI
  80. Hudson R, Laska M, Berger T et al (1994) Olfactory function in patients with hypogonadotropic hypogonadism: an all-or-none phenomenon? Chem Senses 19:57–69. https://doi.org/10.1093/chemse/19.1.57 · DOI
  81. Hutchins BI, Kotan LD, Taylor-Burds C et al (2016) CCDC141 mutation identified in anosmic hypogonadotropic hypogonadism (Kallmann Syndrome) alters GnRH neuronal migration. Endocrinology 157:1956–1966. https://doi.org/10.1210/en.2015-1846 · DOI
  82. Iacovazzo D, Carlsen E, Lugli F et al (2016) Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. Eur J Endocrinol 174:241–250. https://doi.org/10.1530/EJE-15-0832 · DOI
  83. Izumi Y, Suzuki E, Kanzaki S et al (2014) Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. Fertil Steril. https://doi.org/10.1016/j.fertnstert.2014.06.017 · DOI
  84. Jarzabek K, Wolczynski S, Lesniewicz R et al (2012) Evidence that FGFR1 loss-of-function mutations may cause variable skeletal malformations in patients with Kallmann syndrome. Adv Med Sci. https://doi.org/10.2478/v10039-012-0036-4 · DOI
  85. Jayakody SA, Andoniadou CL, Gaston-Massuet C et al (2012) SOX2 regulates the hypothalamic-pituitary axis at multiple levels. J Clin Invest 122:3635–3646. https://doi.org/10.1172/JCI64311 · DOI
  86. Jongmans MCJ, Admiraal RJ, Van Der Donk KP et al (2006) CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. https://doi.org/10.1136/jmg.2005.036061 · DOI · Paper page
  87. Jongmans MCJ, van Ravenswaaij-Arts CMA, Pitteloud N et al (2009) CHD7 mutations in patients initially diagnosed with Kallmann syndrome—the clinical overlap with CHARGE syndrome. Clin Genet. https://doi.org/10.1111/j.1399-0004.2008.01107.x · DOI · Paper page
  88. Känsäkoski J, Fagerholm R, Laitinen EM et al (2014) Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism. Pediatr Res 75:641–644. https://doi.org/10.1038/pr.2014.23 · DOI
  89. Kawamata N, Sakajiri S, Sugimoto K-J et al (2002) A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4. Oncogene 21:4983–4991. https://doi.org/10.1038/sj.onc.1205628 · DOI
  90. Kelberman D, Rizzoti K, Avilion A et al (2006) Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.e. J Clin Invest 116:2442–2455. https://doi.org/10.1172/JCI28658 · DOI · Paper page
  91. Kelberman D, Turton JPG, Woods KS et al (2009) Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD). Clin Endocrinol (Oxf). https://doi.org/10.1111/j.1365-2265.2008.03326.x · DOI
  92. Kevelam SHG, Van Harssel JJT, Van Der Zwaag B et al (2012) A patient with a mild holoprosencephaly spectrum phenotype and heterotaxy and a 1.3 Mb deletion encompassing GLI2. Am J Med Genet Part A. https://doi.org/10.1002/ajmg.a.34350 · DOI
  93. Kim H-G, Layman LC (2011) The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol Cell Endocrinol 346:74–83. https://doi.org/10.1016/j.mce.2011.07.013 · DOI
  94. Kim HG, Kurth I, Lan F et al (2008a) Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet. https://doi.org/10.1016/j.ajhg.2008.09.005 · DOI · Paper page
  95. Kim S-H, Hu Y, Cadman S, Bouloux P (2008b) Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome. J Neuroendocrinol 20:141–163. https://doi.org/10.1111/j.1365-2826.2007.01627.x · DOI · Paper page
  96. Kotan LD, Hutchins BI, Ozkan Y et al (2014) Mutations in FEZF1 cause Kallmann syndrome. Am J Hum Genet 95:326–331. https://doi.org/10.1016/j.ajhg.2014.08.006 · DOI
  97. Kramer PR, Wray S (2000) Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons. Genes Dev 14:1824–1834 · DOI
  98. Kramer PR, Wray S (2001) Nasal embryonic LHRH factor (NELF) expression within the CNS and PNS of the rodent. Brain Res Gene Expr Patterns 1:23–26 · DOI
  99. Kuang X-L, Zhao X-M, Xu H-F et al (2010) Spatio-temporal expression of a novel neuron-derived neurotrophic factor (NDNF) in mouse brains during development. BMC Neurosci 11:137. https://doi.org/10.1186/1471-2202-11-137 · DOI
  100. Kurokawa D, Kiyonari H, Nakayama R et al (2004) Regulation of Otx2 expression and its functions in mouse forebrain and midbrain. Development. https://doi.org/10.1242/dev.01220 · DOI
  101. Kyriakakis N, Shonibare T, Kyaw-Tun J et al (2017) Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center. Pituitary. https://doi.org/10.1007/s11102-017-0822-x · DOI
  102. Laitinen E-M, Vaaralahti K, Tommiska J et al (2011) Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis 6:41. https://doi.org/10.1186/1750-1172-6-41 · DOI · Paper page
  103. Lakhina V, Marcaccio CL, Shao X et al (2012) Netrin/DCC signaling guides olfactory sensory axons to their correct location in the olfactory bulb. J Neurosci 32:4440–4456. https://doi.org/10.1523/JNEUROSCI.4442-11.2012 · DOI
  104. Lalani SR, Safiullah AM, Molinari LM et al (2004) SEMA3E mutation in a patient with CHARGE syndrome. J Med Genet 41:e94. https://doi.org/10.1136/jmg.2003.017640 · DOI
  105. Layman LC, Lee EJ, Peak DB et al (1997) Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene. N Engl J Med. https://doi.org/10.1056/NEJM199708283370905 · DOI · Paper page
  106. Layman LC, Cohen DP, Jin M et al (1998) Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 18:14–15. https://doi.org/10.1038/ng0198-14 · DOI · Paper page
  107. Layman LC, Porto ALA, Xie J et al (2002) FSHβ gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.87.8.3702 · doi:10.1210/jc.87.8.3702
  108. Legouis R, Hardelin JP, Levilliers J et al (1991) The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67:423–435. https://doi.org/10.1016/0092-8674(91)90193-3 · DOI · Paper page
  109. Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L et al (2012) Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab 97:E136–E144. https://doi.org/10.1210/jc.2011-2041 · DOI
  110. Li C, Scott DA, Hatch E et al (2007) Dusp6 (Mkp3) is a negative feedback regulator of FgF-stimulated ERK signaling during mouse development. Development. https://doi.org/10.1242/dev.02701 · DOI · Paper page
  111. Libri DV, Kleinau G, Vezzoli V et al (2014) Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways. J Clin Endocrinol Metab 99:E458–E463. https://doi.org/10.1210/jc.2013-2431 · DOI
  112. Liu G, Beggs H, Jürgensen C et al (2004) Netrin requires focal adhesion kinase and Src family kinases for axon outgrowth and attraction. Nat Neurosci 7:1222–1232. https://doi.org/10.1038/nn1331 · DOI · Paper page
  113. Lo A, Zheng W, Gong Y et al (2011) GATA transcription factors regulate LHβ gene expression. J Mol Endocrinol 47:45–58. https://doi.org/10.1530/JME-10-0137 · DOI
  114. Lofrano-Porto A, Barra GB, Giacomini LA et al (2007) Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med. https://doi.org/10.1056/NEJMoa071999 · DOI · Paper page
  115. Machinis K, Pantel J, Netchine I et al (2001) Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 69:961–968. https://doi.org/10.1086/323764 · DOI · Paper page
  116. Maione L, Brailly-Tabard S, Nevoux J et al (2016) Reversal of congenital hypogonadotropic hypogonadism in a man with Kallmann syndrome due to SOX10 mutation. Clin Endocrinol (Oxf) 85:988–989. https://doi.org/10.1111/cen.13231 · DOI
  117. Maione L, Dwyer AA, Francou B et al (2018) Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing. Eur J Endocrinol 178(3):R55–R80 https://doi.org/10.1530/EJE-17-0749 · DOI
  118. Malone SA, Papadakis GE, Messina A et al (2019) Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism. Elife. https://doi.org/10.7554/eLife.47198 · DOI
  119. Mantovani G, De Menis E, Borretta G et al (2006) DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients. Eur J Endocrinol. https://doi.org/10.1530/eje.1.02132 · DOI
  120. Marcos S, Monnier C, Rovira X et al (2017) Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice. Hum Mol Genet 26:2006–2017. https://doi.org/10.1093/hmg/ddx080 · DOI
  121. Margolin DH, Kousi M, Chan Y-M et al (2013) Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med 368:1992–2003. https://doi.org/10.1056/NEJMoa1215993 · DOI · Paper page
  122. Marsh APL, Heron D, Edwards TJ et al (2017) Mutations in DCC cause isolated agenesis of the corpus callosum with incomplete penetrance. Nat Genet 49:511–514. https://doi.org/10.1038/ng.3794 · DOI · Paper page
  123. Matsumoto S-I, Yamazaki C, Masumoto K-H et al (2006) Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 103:4140–4145. https://doi.org/10.1073/pnas.0508881103 · DOI · Paper page
  124. McCabe MJ, Gaston-Massuet C, Tziaferi V et al (2011a) Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2011-0454 · DOI
  125. McCabe MJ, Gaston-Massuet C, Gregory LC et al (2013) Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia. J Clin Endocrinol Metab 98:E547–E557. https://doi.org/10.1210/jc.2012-3067 · DOI
  126. McCabe MJ, Hu Y, Gregory LC et al (2015) Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD). Mol Cell Endocrinol 417:63–72. https://doi.org/10.1016/j.mce.2015.09.010 · DOI
  127. McCormack SE, Li D, Kim YJ et al (2017) Digenic inheritance of PROKR2 and WDR11 mutations in pituitary stalk interruption syndrome. J Clin Endocrinol Metab 102:2501–2507. https://doi.org/10.1210/jc.2017-00332 · DOI
  128. McNay DEG, Turton JP, Kelberman D et al (2007) HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2006-1609 · DOI · Paper page
  129. Men M, Wu J, Zhao Y et al (2019) Genotypic and phenotypic spectra of FGFR1, FGF8, and FGF17 mutations in a Chinese cohort with idiopathic hypogonadotropic hypogonadism. Fertil Steril. https://doi.org/10.1016/j.fertnstert.2019.08.069 · DOI
  130. Mengen E, Tunc S, Kotan LD et al (2016) Complete idiopathic hypogonadotropic hypogonadism due to homozygous GNRH1 mutations in the mutational hot spots in the region encoding the decapeptide. Horm Res Paediatr 85:107–111. https://doi.org/10.1159/000441977 · DOI
  131. Messina A, Giacobini P (2013) Semaphorin signaling in the development and function of the gonadotropin hormone-releasing hormone system. Front Endocrinol (Lausanne) 4:133. https://doi.org/10.3389/fendo.2013.00133 · DOI
  132. Messina A, Ferraris N, Wray S et al (2011) Dysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet 20:4759–4774. https://doi.org/10.1093/hmg/ddr403 · DOI
  133. Messina A, Pulli K, Santini S et al (2020) Neuron-derived neurotrophic factor is mutated in congenital hypogonadotropic hypogonadism. Am J Hum Genet 106:58–70. https://doi.org/10.1016/j.ajhg.2019.12.003 · DOI
  134. Ming AYK, Yoo E, Vorontsov EN et al (2012) Dynamics and distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex. J Biol Chem. https://doi.org/10.1074/jbc.M111.325670 · DOI
  135. Miura K, Acierno JS, Seminara SB (2004) Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J Hum Genet 49:265–268. https://doi.org/10.1007/s10038-004-0137-4 · DOI
  136. Muscatelli F, Strom TM, Walker AP et al (1994) Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature. https://doi.org/10.1038/372672a0 · DOI · Paper page
  137. Nakamura Y, Matsumoto H, Zaha K et al (2018) TUBB3 E410K syndrome with osteoporosis and cough syncope in a patient previously diagnosed with atypical Moebius syndrome. Brain Dev 40:233–237. https://doi.org/10.1016/j.braindev.2017.12.006 · DOI
  138. Navarro VM (2013) Interactions between kisspeptins and neurokinin B. Adv Exp Med Biol 784:325–347. https://doi.org/10.1007/978-1-4614-6199-9_15 · DOI
  139. Navarro VM, Gottsch ML, Chavkin C et al (2009) Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. J Neurosci 29:11859–11866. https://doi.org/10.1523/JNEUROSCI.1569-09.2009 · DOI · Paper page
  140. Newbern K, Natrajan N, Kim H-G et al (2013) Identification of HESX1 mutations in Kallmann syndrome. Fertil Steril 99:1831–1837. https://doi.org/10.1016/j.fertnstert.2013.01.149 · DOI
  141. Ng KL (2005) Dependence of olfactory bulb neurogenesis on Prokineticin 2 signaling. Science 308:1923–1927. https://doi.org/10.1126/science.1112103 · DOI · Paper page
  142. Nickell MD, Breheny P, Stromberg AJ, McClintock TS (2012) Genomics of mature and immature olfactory sensory neurons. J Comp Neurol 520:2608–2629. https://doi.org/10.1002/cne.23052 · DOI
  143. Nunziata A, Borck G, Funcke J-B et al (2017) Estimated prevalence of potentially damaging variants in the leptin gene. Mol Cell Pediatr. https://doi.org/10.1186/s40348-017-0074-x · DOI
  144. Oleari R, Caramello A, Campinoti S et al (2019a) PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons. Development. https://doi.org/10.1242/dev.176461 · DOI
  145. Oleari R, Lettieri A, Paganoni A et al (2019b) Semaphorin signaling in GnRH neurons: from development to disease. Neuroendocrinology 109:193–199. https://doi.org/10.1159/000495916 · DOI
  146. Oliveira LM, Seminara SB, Beranova M et al (2001) The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 86:1532–1538. https://doi.org/10.1210/jcem.86.4.7420 · DOI · Paper page
  147. Olsen SK, Li JYH, Bromleigh C et al (2006) Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. https://doi.org/10.1101/gad.1365406 · DOI · Paper page
  148. Olson LE, Tollkuhn J, Scafoglio C et al (2006) Homeodomain-mediated β-catenin-dependent switching events dictate cell-lineage determination. Cell. https://doi.org/10.1016/j.cell.2006.02.046 · DOI · Paper page
  149. Palmert MR, Boepple PA (2001) Commentary: variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab 86:2364–2368 · doi:10.1210/jcem.86.6.7603 · Paper page
  150. Pask AJ, Kanasaki H, Kaiser UB et al (2005) A novel mouse model of hypogonadotrophic hypogonadism: N-ethyl-N-nitrosourea-induced gonadotropin-releasing hormone receptor gene mutation. Mol Endocrinol 19:972–981. https://doi.org/10.1210/me.2004-0192 · DOI
  151. Pasterkamp RJ, De Winter F, Holtmaat AJ, Verhaagen J (1998) Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J Neurosci 18:9962–9976 · DOI · Paper page
  152. Pfaeffle RW, Savage JJ, Hunter CS et al (2007) Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2006-2177 · DOI
  153. Pfaeffle RW, Hunter CS, Savage JJ et al (2008) Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies. J Clin Endocrinol Metab 93:1062–1071. https://doi.org/10.1210/jc.2007-1525 · DOI
  154. Pingault V, Ente D, Le Moal FD et al (2010) Review and update of mutations causing Waardenburg syndrome. Hum Mutat 31(4):391–406. https://doi.org/10.1002/humu.21211 · DOI · Paper page
  155. Pingault V, Bodereau V, Baral V et al (2013) Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. Am J Hum Genet 92:707–724. https://doi.org/10.1016/j.ajhg.2013.03.024 · DOI · Paper page
  156. Pitteloud N, Boepple PA, DeCruz S et al (2001) The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor1. J Clin Endocrinol Metab 86:2470–2475. https://doi.org/10.1210/jcem.86.6.7542 · DOI
  157. Pitteloud N, Hayes FJ, Boepple PA et al (2002) The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:152–160. https://doi.org/10.1210/jcem.87.1.8131 · DOI · Paper page
  158. Pitteloud N, Acierno JS, Meysing A et al (2006) Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.0600962103 · DOI · Paper page
  159. Pitteloud N, Quinton R, Pearce S et al (2007a) Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 117:457–463. https://doi.org/10.1172/JCI29884 · DOI · Paper page
  160. Pitteloud N, Durrani S, Raivio T, Sykiotis GP (2010) Complex genetics in idiopathic hypogonadotropic hypogonadism. Kallmann syndrome and hypogonadotropic hypogonadism. KARGER, Basel, pp 142–153 · DOI
  161. Pozza SBD, Hiedl S, Roeb J et al (2012) A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency. Horm Res Paediatr 77(1):41–51. https://doi.org/10.1159/000335929 · DOI
  162. Quennell JH, Mulligan AC, Tups A et al (2009) Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Endocrinology. https://doi.org/10.1210/en.2008-1693 · DOI · Paper page
  163. Quinton R, Cheow HK, Tymms DJ et al (1999) Kallmann’s syndrome: is it always for life? Clin Endocrinol (Oxf) 50:481–485. https://doi.org/10.1046/j.1365-2265.1999.00708.x · DOI
  164. Quinton R, Duke VM, Robertson A et al (2001) Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) 55:163–174. https://doi.org/10.1046/j.1365-2265.2001.01277.x · DOI · Paper page
  165. Raivio T, Falardeau J, Dwyer A et al (2007) Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 357:863–873. https://doi.org/10.1056/NEJMoa066494 · DOI · Paper page
  166. Raivio T, Avbelj M, McCabe MJ et al (2012) Genetic overlap in kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 97:E694–E699. https://doi.org/10.1210/jc.2011-2938 · DOI · Paper page
  167. Ribeiro RS, Vieira TC, Abucham J (2007) Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review. Eur J Endocrinol 156:285–290. https://doi.org/10.1530/eje.1.02342 · DOI · Paper page
  168. Robinson M, Parsons Perez MC, Tébar L et al (2004) FLRT3 is expressed in sensory neurons after peripheral nerve injury and regulates neurite outgrowth. Mol Cell Neurosci. https://doi.org/10.1016/j.mcn.2004.06.008 · DOI
  169. Romero CJ, Pine-Twaddell E, Radovick S (2011) Novel mutations associated with combined pituitary hormone deficiency. J Mol Endocrinol 46(3):R93–R102. https://doi.org/10.1530/JME-10-0133 · DOI
  170. Root AW (2010) Reversible isolated hypogonadotropic hypogonadism due to mutations in the neurokinin B regulation of gonadotropin-releasing hormone release. J Clin Endocrinol Metab 95:2625–2629. https://doi.org/10.1210/jc.2010-0733 · DOI
  171. Ross RA, Leon S, Madara JC et al (2018) PACAP neurons in the ventral premammillary nucleus regulate reproductive function in the female mouse. Elife. https://doi.org/10.7554/eLife.35960 · DOI
  172. de Roux N, Young J, Brailly-Tabard S et al (1999) The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred1. J Clin Endocrinol Metab 84:567–572. https://doi.org/10.1210/jcem.84.2.5449 · DOI
  173. de Tassigny XA, Fagg LA, Dixon JPC et al (2007) Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci 104:10714–10719. https://doi.org/10.1073/pnas.0704114104 · DOI · Paper page
  174. Rugarli EI, Ghezzi C, Valsecchi V, Ballabio A (1996) The Kallmann syndrome gene product expressed in COS cells is cleaved on the cell surface to yield a diffusible component. Hum Mol Genet 5:1109–1115. https://doi.org/10.1093/hmg/5.8.1109 · DOI
  175. Salenave S, Chanson P, Bry H et al (2008) Kallmann’s syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab 93:758–763. https://doi.org/10.1210/jc.2007-1168 · DOI
  176. Santhakumar A, Balasubramanian R, Miller M, Quinton R (2014) Reversal of isolated hypogonadotropic hypogonadism: long-term integrity of hypothalamo-pituitary-testicular axis in two men is dependent on intermittent androgen exposure. Clin Endocrinol (Oxf) 81:473–476 · DOI
  177. Sarfati J, Dodé C, Young J (2010) Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations. Front Horm Res 39:121–132. https://doi.org/10.1159/000312698 · DOI
  178. Sasaki G, Ogata T, Ishii T et al (2002) Novel mutation of TBX3 in a Japanese family with ulnar-mammary syndrome: implication for impaired sex development. Am J Med Genet 110:365–369. https://doi.org/10.1002/ajmg.10447 · DOI
  179. Sato N, Katsumata N, Kagami M et al (2004) Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab 89:1079–1088. https://doi.org/10.1210/jc.2003-030476 · DOI · Paper page
  180. Sbai O, Monnier C, Dodé C et al (2014) Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations. FASEB J 28:3734–3744. https://doi.org/10.1096/fj.13-243402 · DOI
  181. Schang AL, Granger A, Quérat B et al (2013) GATA2-induced silencing and LIM-homeodomain protein-induced activation are mediated by a Bi-functional response element in the rat GnRH receptor gene. Mol Endocrinol. https://doi.org/10.1210/me.2012-1182 · DOI
  182. Schilter KF, Schneider A, Bardakjian T et al (2011) OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clin Genet. https://doi.org/10.1111/j.1399-0004.2010.01450.x · DOI
  183. Schwanzel-Fukuda M, Bick D, Pfaff DW (1989) Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res 6:311–326. https://doi.org/10.1016/0169-328X(89)90076-4 · DOI · Paper page
  184. Schwarting GA, Raitcheva D, Bless EP et al (2004) Netrin 1-mediated chemoattraction regulates the migratory pathway of LHRH neurons. Eur J Neurosci 19:11–20. https://doi.org/10.1111/j.1460-9568.2004.03094.x · DOI
  185. Seeburg PH, Adelman JP (1984) Characterization of cDNA for precursor of human luteinizing hormone releasing hormone. Nature 311:666–668. https://doi.org/10.1038/311666a0 · DOI · Paper page
  186. Seifi M, Walter MA (2018) Axenfeld-Rieger syndrome. Clin Genet 93:1123–1130. https://doi.org/10.1111/cge.13148 · DOI · Paper page
  187. Seminara SB, Acierno JS, Abdulwahid NA et al (2002) Hypogonadotropic hypogonadism and cerebellar ataxia: detailed phenotypic characterization of a large, extended kindred. J Clin Endocrinol Metab 87:1607–1612. https://doi.org/10.1210/jcem.87.4.8384 · doi:10.1210/jcem.87.4.8384
  188. Semple RK, Achermann JC, Ellery J et al (2005) Two novel missense mutations in G protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 90:1849–1855. https://doi.org/10.1210/jc.2004-1418 · DOI · Paper page
  189. Shaw ND, Brand H, Kupchinsky ZA et al (2017) SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nat Genet 49:238–248. https://doi.org/10.1038/ng.3743 · DOI
  190. Sheng HZ, Moriyama K, Yamashita T et al (1997) Multistep control of pituitary organogenesis. Science 278:1809–1812. https://doi.org/10.1126/science.278.5344.1809 · DOI · Paper page
  191. Shi C-H, Schisler JC, Rubel CE et al (2014) Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet 23:1013–1024. https://doi.org/10.1093/hmg/ddt497 · DOI
  192. Sidhoum VF, Chan Y-M, Lippincott MF et al (2014) Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab 99:861–870. https://doi.org/10.1210/jc.2013-2809 · DOI · Paper page
  193. Simonis N, Migeotte I, Lambert N et al (2013) FGFR1 mutations cause hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly. J Med Genet. https://doi.org/10.1136/jmedgenet-2013-101603 · DOI
  194. Sinisi AA, Asci R, Bellastella G et al (2008) Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum Reprod 23:2380–2384. https://doi.org/10.1093/humrep/den247 · DOI
  195. Sisodiya SM, Ragge NK, Cavalleri GL et al (2006) Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia 47:534–542. https://doi.org/10.1111/j.1528-1167.2006.00464.x · DOI
  196. Smith JT, Acohido BV, Clifton DK, Steiner RA (2006) KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 18:298–303. https://doi.org/10.1111/j.1365-2826.2006.01417.x · DOI · Paper page
  197. Soussi-Yanicostas N, Hardelin JP, Arroyo-Jimenez MM et al (1996) Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci 109(Pt 7):1749–1757 · DOI
  198. Soussi-Yanicostas N, de Castro F, Julliard AK et al (2002) Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 109:217–228. https://doi.org/10.1016/s0092-8674(02)00713-4 · DOI · Paper page
  199. Spilker C, Grochowska KM, Kreutz MR (2016) What do we learn from the murine Jacob/Nsmf gene knockout for human disease? Rare Dis (Austin, Tex) 4:e1241361. https://doi.org/10.1080/21675511.2016.1241361 · DOI
  200. Srour M, Riviere JB, Pham JMT et al (2010) Mutations in DCC cause congenital mirror movements. Science 328:592–592. https://doi.org/10.1126/science.1186463 · DOI · Paper page

200 of 243 shown

Cited by

See all 175

Metadata

Authors
Cangiano, B., Swee, D. S., Quinton, R., & Bonomi, M.
Venue
Human Genetics
Published
2020-03-21
Volume
140
Issue
1
Pages
77-111
ISSN
  • 0018-7348 (ISSN-L)
  • 0340-6717
  • 1432-1203
OpenAlex
W3012871603
Cited by
175
References
41
FWCI
20.61
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease. https://app.cochat.ai/papers/10.1007/s00439-020-02147-1
The paper
Cangiano, B., Swee, D. S., Quinton, R., & Bonomi, M. (2021). Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease. Human Genetics. https://doi.org/10.1007/s00439-020-02147-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.